Tags:DevelopmentDrugHardwareHealthTechInformationLearnMarketMedtechProductSpecialty
Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. View our community guidelines: http://bit.ly/2H9QmH5
Location: Canada, Ontario, Northbrook
Member count: 11-50
Total raised: $30M
Founded date: 2004

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
27.04.2022-$30M--

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
19.08.2022Covid-19 r...The clock is ticking for penny...-Tyler Patc...endpts.com...
27.04.2022Clarus The...NORTHBROOK, Ill., April 27, 20...--globenewsw...
25.04.2022Clarus The...NORTHBROOK, Ill., April 25, 20...--globenewsw...
25.05.2021Clarus The... NORTHBROOK, Ill. and NORTH A...--prnewswire...
27.04.2021Blue Water...NORTHBROOK, Ill. and GREENWICH...--marketscre...
27.04.2021BLUE WATER...NORTHBROOK, Ill. and GREENWICH...--marketscre...